Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Roivant Sciences Ltd. (ROIVW)

    Price:

    2.75 USD

    ( + 0.12 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    ROIVW
    Name
    Roivant Sciences Ltd.
    Industry
    Biotechnology
    Sector
    Healthcare
    Price
    2.750
    Market Cap
    1.968B
    Enterprise value
    4.704B
    Currency
    USD
    Ceo
    Matthew Gline
    Full Time Employees
    620
    Ipo Date
    2021-09-27
    City
    London
    Address
    11-12 St. James’s Square

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    BioNTech SE

    VALUE SCORE:

    6

    Symbol
    BNTX
    Market Cap
    22.626B
    Industry
    Biotechnology
    Sector
    Healthcare

    2nd position

    ADMA Biologics, Inc.

    VALUE SCORE:

    11

    Symbol
    ADMA
    Market Cap
    3.694B
    Industry
    Biotechnology
    Sector
    Healthcare

    The best

    Harmony Biosciences Holdings, Inc.

    VALUE SCORE:

    12

    Symbol
    HRMY
    Market Cap
    1.624B
    Industry
    Biotechnology
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -24.620
    P/S
    1.537k
    P/B
    4.667
    Debt/Equity
    0.049
    EV/FCF
    -25.026
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    1.442k
    Earnings yield
    -0.041
    Debt/assets
    0.040
    FUNDAMENTALS
    Net debt/ebidta
    1.252
    Interest coverage
    0
    Research And Developement To Revenue
    47.190
    Intangile to total assets
    0
    Capex to operating cash flow
    -0.010
    Capex to revenue
    0.583
    Capex to depreciation
    -1.691
    Return on tangible assets
    -0.155
    Debt to market cap
    0.010
    Piotroski Score
    2.000
    FUNDAMENTALS
    PEG
    0.227
    P/CF
    -26.315
    P/FCF
    -26.753
    RoA %
    -15.487
    RoIC %
    -23.905
    Gross Profit Margin %
    91.210
    Quick Ratio
    30.664
    Current Ratio
    30.664
    Net Profit Margin %
    -6.080k
    Net-Net
    6.140
    FUNDAMENTALS PER SHARE
    FCF per share
    -1.100
    Revenue per share
    0.019
    Net income per share
    -1.161
    Operating cash flow per share
    -1.089
    Free cash flow per share
    -1.100
    Cash per share
    6.501
    Book value per share
    7.138
    Tangible book value per share
    7.138
    Shareholders equity per share
    6.126
    Interest debt per share
    0.298
    TECHNICAL
    52 weeks high
    2.860
    52 weeks low
    2.630
    Current trading session High
    2.860
    Current trading session Low
    2.630
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    GB
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    -294.11764%
    P/E
    -477.701

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -100.936

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -77.870

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -16.833

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -35.537

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -27.514

    No data to display

    logo

    Country
    AU
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -4.546

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -20.072

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -57.285

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -41.221

    No data to display

    DESCRIPTION

    Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

    NEWS